Fat Embolism Syndrome
A triad of hypoxemia, altered mental status, and petechial rash occurring 24-72 hours after long bone fractures, caused by fat globules entering the bloodstream.
Emergency Management: Fulminant FES causing sudden right heart failure and cardiac arrest requires ACLS and potentially VA-ECMO support as a bridge to recovery.
Fat Embolism Syndrome (FES) is a life-threatening complication characterized by the presence of fat globules in the pulmonary and systemic circulation, leading to a classic triad of hypoxemia, neurological abnormalities, and a petechial rash. It typically occurs 24 to 72 hours after major trauma, most commonly long bone or pelvic fractures.
Detailed Overview
While asymptomatic fat emboli are very common following major orthopedic trauma, the clinical syndrome (FES) occurs in only 1-3% of patients with long bone fractures. FES is caused by fat macroglobules physically obstructing capillary beds (especially in the lungs and brain) and by the biochemical toxicity of free fatty acids causing endothelial damage and systemic inflammatory response syndrome (SIRS). Early surgical stabilization of fractures is the most effective way to prevent FES.
Epidemiology & Demographics
Occurs in 1-3% of patients with single long bone fractures, but incidence rises up to 10% in patients with multiple fractures or pelvic fractures. Highest incidence is in young adults (due to high-energy trauma) and the elderly (hip fractures).
Etiological Mechanism
The primary cause is severe physical trauma to bone marrow, causing fat disruption and venous intravasation. Non-trauma causes are rare but include acute pancreatitis, cardiopulmonary bypass, lipid infusion, and sickle cell crisis.
Primary Causes
["Trauma: Fractures of the femur, tibia, and pelvis.", "Orthopedic Procedures: Intramedullary reaming/nailing, total joint arthroplasty."]
Two theories exist: 1) Mechanical Theory: Trauma disrupts venous sinusoids in the marrow, allowing fat droplets to enter circulation and embolize the pulmonary capillary bed, causing V/Q mismatch and shunting. Microemboli can pass through a patent foramen ovale (or via pulmonary microcirculation) to the systemic circulation, hitting the brain and skin. 2) Biochemical Theory: Marrow fat degrades into free fatty acids (FFAs) via tissue lipases. FFAs are highly toxic to pneumocytes and capillary endothelium, leading to ARDS-like lung injury, capillary leak, and microhemorrhages (petechiae).
Diagnostic Criteria & Guidelines
Diagnosis is clinical, often using Gurd's Criteria. Requires 1 major and 4 minor criteria. Major: Respiratory insufficiency, cerebral involvement, petechial rash. Minor: Tachycardia, fever >39C, retinal changes (fat or petechiae), jaundice, renal signs, drop in platelets, high ESR, fat macroglobulinemia.
Supportive care is paramount. Continuous oxygen therapy. If severe, intubation and mechanical ventilation using ARDSNet protocols (low tidal volumes 6 mL/kg PBW, optimized PEEP) are required. Hemodynamic support with IV fluids and vasopressors as needed.
Second-Line & Adjunctive Therapy
There is no specific medical therapy. High-dose corticosteroids (e.g., Methylprednisolone) have been studied for prophylaxis and treatment but are generally NOT recommended as standard of care due to lack of proven mortality benefit and increased infection risk.
Surgical & Procedural Management
Preventative: Early operative fixation of long bone fractures (within 24 hours) is the single best intervention to prevent FES.
Patient Counseling & Advice
Counsel family members on the critical nature of the ICU course, the possibility of prolonged mechanical ventilation, and the potential for gradual neurologic recovery.
Follow-Up & Monitoring Schedule
Post-discharge monitoring for residual pulmonary dysfunction and cognitive or motor deficits due to brain micro-infarcts.
Preventive Strategies
Early immobilization and prompt surgical fixation of fractures. Gentle surgical technique during intramedullary nailing.
Mortality is estimated at 5-15%, primarily due to severe ARDS. Most patients who survive the acute pulmonary phase recover fully, though some neurologic deficits can linger.